Program Page
SUNDAY, NOVEMBER 17
Monday, NOVEMBER 18
- Plenary Session 1: Organ-Specific Microenvironments and Metastasis
- Plenary Session 2: Systemic Macroenvironment and Metastasis: Effects of Aging and Stress
- Plenary Session 3: The Metabolic Microenvironment, including Immune Metabolism
- Plenary Session 4: Metabolic Macroenvironment: Obesity and Cancer Cachexia
Tuesday, NOVEMBER 19
- Plenary Session 5: Stromal Changes as Tissue Becomes Tumor: The Expanding Functions of TME Components
- Plenary Session 6: Multicellular Interactions within Tumor Immune Microenvironments
- Plenary Session 7: Inflammation, the Immune Microenvironment, and the Systemic Interface
Wednesday, NOVEMBER 20
- Plenary Session 8: Microbiome and Immune Therapy
- Plenary Session 9: Therapy-induced Changes in Organ-specific Microenvironment and Therapeutic Strategies for Targeting the TME
- Closing Remarks
Sunday, November 17
REGISTRATION
4-8 P.M.
Welcome and Introduction
5:30-6:15 P.M.
- Mikala Egeblad, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
- Neta Erez, Tel Aviv University, Tel Aviv, Israel
- Sergei Grivennikov, Cedars-Sinai Medical Center, Los Angeles, California
- Ilaria Malanchi, The Francis Crick Institute, London, England
Opening Keynote Address
6:15-7P.M.
CME-Eligible
- Introduction of keynote speaker
- Title to be announced
Ashani T. Weeraratna, John Hopkins University, Baltimore, Maryland
Monday, November 18
Continental Breakfast
7-8 a.m.
Plenary Session 1: Organ-Specific Microenvironments and Metastasis
8-10 a.m.
CME-Eligible
- Understanding and overcoming the numbers game that underlies disseminated tumor cell immune evasion
Cyrus M. Ghajar, Fred Hutch Cancer Center, Seattle, Washington - Title to be announced
Ilaria Malanchi, The Francis Crick Institute, London, United Kingdom - Dissecting plasticity during colorectal cancer metastasis
Karuna Ganesh, Memorial Sloan-Kettering Cancer Center, New York, New York
Short-talks from highly-rated abstract
Break
10-10:30 a.m.
Plenary Session 2: Systemic Macroenvironment and Metastasis: Effects of Aging and Stress
10:30 a.m.-12:30 P.M.
CME-Eligible
- Title to be announced
Mikala Egeblad, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York - Understanding the immune macroenvironment to improve outcomes for older breast cancer patients
Sandra S. McAllister, Brigham and Women’s Hospital, Boston, MA - Respiratory virus infections promote metastatic outgrowth through alterations in immune landscapes
James V. DeGregori, University of Colorado Anschutz Medical Campus, Aurora, Colorado
Short-talks from highly-rated abstract
Lunch on Own
12:30-2:30 P.M.
Plenary Session 3: The Metabolic Microenvironment, including Immune Metabolism
2:30-4:30 P.M.
CME-Eligible
- Systemic and local metabolites controlling cancer immunity
Greg M. Delgoffe, University of Pittsburgh, Pittsburgh, Pennsylvania - Modulating amino acid cross talk between cancer and the host to improve diagnosis and therapy
Ayelet Erez, Weizman Institute of Science, Rehovot, Israel - Metabolic networks in the tumor microenvironment
Costas Lyssiotis, University of Michigan, Ann Arbor, Michigan
Short-talks from highly-rated abstract
Break
4:30 pm-5:00 P.M.
Plenary Session 4: Metabolic Macroenvironment: Obesity and Cancer Cachexia
5-7 P.M.
CME-Eligible
- Intratumoral immune cells and their role in cancer cachexia
Marcus DaSilva Gonsalves, Weill Cornell Medicine, New York, New York - TitLydia Lynch, Brigham and Women’s Hospital, Boston, Massachusetts
- Swarnali Acharya, Columbia University, New York, New York
Short-talks from highly-rated abstract
Lightning Talks
7:30-9 p.m.
POSTER SESSION A AND RECEPTION
7-8:30 P.M.
Tuesday, November 19
Continental Breakfast
7-8 a.m.
Plenary Session 5: Stromal Changes as Tissue Becomes Tumor: The Expanding Functions of TME Components
8-10:15 a.m.
CME-Eligible
- Neta Erez, Tel Aviv University, Tel Aviv, Israel
- Edna Cukierman, Fox Chase Cancer Center, Philadelphia, Pennsylvania
- Kairbaan Hodivala-Dilke, Cancer Research UK, London, United Kingdom
- Vascular control of metastasis
Hellmut, Augustin, Heidelberg University & German Cancer Research Center (DKFZ) Heidelberg, Germany
Short-talk from highly-rated abstract
BREAK
10:15-10:45 a.m.
Plenary Session 6: Multicellular Interactions within Tumor Immune Microenvironments
10:45 A.m-12:45 p.m.
CME-Eligible
- Lisa Coussens, Oregon Health and Science University, Portland, Oregon
- Modulation of pancreatic tumor microenvironment and immune response
Yulia Pylaeva-Gupta, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina - Cedric Blanpain, Free University of Brussels, Brussels, Belgium
Short-talks from highly-rated abstract
Lunch on own
12:45-2:30 p.m.
Plenary Session 7: Inflammation, the Immune Microenvironment, and the Systemic Interface
2:30-4:30 p.m.
CME-Eligible
- Title to be announced
Leah M. Cook, Nebraska Medical Center, Omaha, Nebraska - Microbes and cytokines regulating tumor microenvironment and metastasis
Sergei Grivennikov, Cedars-Sinai Medical Center, Los Angeles, California - Dissecting how breast tumours hijack myelopoiesis to promote metastasis
Karin E. de Visser, Netherlands Cancer Institute, Amsterdam, Netherlands
Short-talks from highly-rated abstract
LIGHTNING TALKS
4:30-5 P.M.
POSTER SESSION B AND RECEPTION
4:30-6 P.M.
Tuesday, November 19
Continental Breakfast
7-8 a.m.
Plenary Session 8: Microbiome and Immune Therapy
8-10 a.m.
CME-Eligible
- Systemic and local metabolites controlling cancer immunity
Susan Bullman, Fred Hutch Cancer Center, Seattle, Washington - Florencia McAllister, University of Texas MD Anderson Cancer Center, Houston, Texas
- Giorgio Trinchieri, National Institute of Health, Bethesda, Maryland
Short-talks from highly-rated abstract
BREAK
10-10:30 a.m.
Plenary Session 9: Therapy-induced Changes in Organ-specific Microenvironment and Therapeutic Strategies for Targeting the TME
10:30 a.m-12:30 p.m.
CME-Eligible
- Title to be announced
Adrienne Boire, Memorial Sloan Kettering Cancer Center, New York, New York - Age-related stromal changes drive tumorigenesis
Sheila A. Stewart, Washington University School of Medicine, St. Louis, Missouri - Implicit order, disease, and cancer
Garry P. Nolan, Stanford University School of Medicine, Stanford, California
Short-talks from highly-rated abstract